Document Detail

Respiratory distress syndrome and inositol supplementation in preterm infants.
MedLine Citation:
PMID:  3539028     Owner:  NLM     Status:  MEDLINE    
We report a randomised double blind trial of myo-inositol (inositol) supplementation for 10 days in 74 preterm infants with a birth weight less than 2000 g (mean gestational age 29.5 weeks and mean birth weight 1266 g). All infants required artificial ventilation for treatment of respiratory distress syndrome. Inositol (120-160 mg/kg/day) was administered by the ingastric or intravenous route. The 37 infants who received inositol supplementation required less mechanical ventilation during days 4-10, had less failures of indomethacin to close ductus arteriosus, and had less deaths or bronchopulmonary dysplasia, or both, than the infants treated with placebo. There were no detectable adverse effects. These preliminary results suggest that inositol is an important nutrient in immature preterm infants.
M Hallman; A L Järvenpää; M Pohjavuori
Related Documents :
24379238 - Intraventricular hemorrhage and neurodevelopmental outcomes in extreme preterm infants.
10228288 - Short versus prolonged indomethacin therapy for patent ductus arteriosus in preterm inf...
15892548 - Fatigue assessment in the field: validation of a hand-held electronic psychomotor vigil...
6642048 - Indomethacin and the fetal renal nonfunction syndrome.
15296148 - Growth enhancement of etbe-degrading bacterial consortium with various carbon sources.
10776198 - The usefulness of an assessment of emotional involvement of hiv-positive mothers and th...
Publication Detail:
Type:  Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Archives of disease in childhood     Volume:  61     ISSN:  1468-2044     ISO Abbreviation:  Arch. Dis. Child.     Publication Date:  1986 Nov 
Date Detail:
Created Date:  1987-01-20     Completed Date:  1987-01-20     Revised Date:  2009-11-18    
Medline Journal Info:
Nlm Unique ID:  0372434     Medline TA:  Arch Dis Child     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  1076-83     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Clinical Trials as Topic
Double-Blind Method
Gestational Age
Infant, Newborn
Inositol / therapeutic use*
Respiration, Artificial
Respiratory Distress Syndrome, Newborn / drug therapy*,  mortality,  therapy
Reg. No./Substance:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Breast milk jaundice in premature infants.
Next Document:  Sonographic finding of the bright thalamus.